针对可切除皮肤鳞状细胞癌（cSCC）患者的围手术期 MK-4280A（Favezelimab 和 Pembrolizumab 的复方制剂）与 Pembrolizumab 的随机、双盲、2 期研究

{"title":"针对可切除皮肤鳞状细胞癌（cSCC）患者的围手术期 MK-4280A（Favezelimab 和 Pembrolizumab 的复方制剂）与 Pembrolizumab 的随机、双盲、2 期研究","authors":"S.A. Koyfman, A.W. Silk, D. Davar, D. Schadendorf, J.R. Clark, R. Ladwa, J. Lee, L. Suttner, R. Groisberg, F. Jin, G.J. Hanna","doi":"10.1016/j.ijrobp.2024.01.191","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"5 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)\",\"authors\":\"S.A. Koyfman, A.W. Silk, D. Davar, D. Schadendorf, J.R. Clark, R. Ladwa, J. Lee, L. Suttner, R. Groisberg, F. Jin, G.J. Hanna\",\"doi\":\"10.1016/j.ijrobp.2024.01.191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14219,\"journal\":{\"name\":\"International Journal of Radiation Oncology*Biology*Physics\",\"volume\":\"5 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology*Biology*Physics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijrobp.2024.01.191\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology*Biology*Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.01.191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}